|
|
|
Corporate Profile: Angiochem
| Summary: |
Angiochem is focused on research and development of pharmaceuticals for treatment of patients with CNS diseases.
|
| Address (HQ): |
201 President-Kennedy Avenue
Suite PK-2880
Montreal, QC H2X 3Y7
Canada |
| Phone #'s (HQ): |
| Main |
(514) 788-7800 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(514) 788-7801 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
